Common Name(s): L-arginine is known by the names Arginine and L-arginine.
L-arginine is classed as a non-essential amino acid, however it may be regarded essential or semi-essential under stressful conditions, when L-arginine synthesis is impaired. Due to its antiatherogenic, anti-ischemic, antiplatelet, and antithrombotic qualities, L-arginine has been examined for usage in cardiovascular illness as well as renal disease, diabetes, cystic fibrosis, sickle cell disease, and erectile dysfunction. Moreover, its immunostimulatory actions and prospective advantages in ocular diseases and preeclampsia have been assessed.
L-arginine dosing for a number of disorders has been researched using various dosages and treatment periods; current daily dosage trends range from 6 to 30 g orally in 3 split doses. Oral and intravenous (IV) preparations have been the subject of the majority of research.
No contraindications have been discovered. Nevertheless, L-arginine is contraindicated after acute myocardial infarction.
L-arginine supplementation has demonstrated favorable effects in hypertensive and preeclamptic women. L-arginine should only be taken in these populations if prescribed by and under the supervision of a health care professional, due to the paucity of research on its safety and efficacy during pregnancy and lactation.
Nitrates: Patients concurrently taking L-arginine supplements and nitrates should exercise caution. L-arginine may enhance the effects of isosorbide mononitrate and other nitric oxide donors, including glyceryl trinitrate (often known as nitroglycerin) and sodium nitroprusside. Insulin: Patients taking insulin concurrently with L-arginine should exercise caution, as the effects on insulin are uncertain. Those utilizing cholesterol-lowering medicines concurrently with L-arginine should exercise caution; the effects of cholesterol-lowering therapies are unknown.
Use of L-arginine has been associated with nausea, diarrhea, dyspepsia, palpitations, headache, and numbness. Higher doses may cause a bitter taste. Due to the vasodilatory effects of L-arginine, hypotension may ensue. The high chloride content of IV formulations containing L-arginine hydrochloride may raise the risk of metabolic acidosis in individuals with electrolyte abnormalities. In patients with renal and/or hepatic dysfunction, hyperkalemia and elevated serum urea nitrogen (BUN) values are possible.
Nitric oxide in high amounts is considered harmful to brain tissue.
Around 80% of arginine is derived from protein ingestion and protein breakdown. The remaining arginine is produced endogenously from scratch by the kidneys. 2017 for Morris Meats (e.g., shellfish, pig), milk and milk products, chocolate, watermelon, legumes (e.g., soybeans, chickpeas), oats and wheats, and nuts are sources of the amino acid arginine (eg, peanuts, walnuts). McNeal 2016 Proteins are hydrolyzed enzymatically or chemically to produce L-arginine, their physiologically active form. From gelatin hydrolysate, arginine can be precipitated in the laboratory. L-arginine can also be produced from L-ornithine and cyanamide in the presence of barium hydroxide in an aqueous solution. Budavari 1989 As L-arginine may be produced endogenously from L-citrulline, it is not a necessary amino acid for adults. L-arginine synthesis may be reduced in youngsters and persons with specific diseases (e.g., infection, trauma) in which case L-arginine may be regarded semi-essential. Morris 2017, Schwedhelm 2008
L-arginine is often promoted as a dietary supplement with claims of cardiovascular disease benefits.
Cheng 2001 and dysfunctional erections.
Cumpanas 2009, Gentile 2009 L-arginine was initially extracted from bovine horn as the stereoisomer of arginine in the 1800s. Cheng, 2001
L-arginine (C6H14N4O2), also known as 2-amino-5-guanidino-pentanoic acid, is a conditionally necessary acid in mammals whose L-form is physiologically active.
Calabro 2014, NIH 2018 In humans, it is produced from glutamine, glutamate, and proline by the intestinal-renal axis. Morris 2017; Wu 2017 2009 The portion of the side chain nearest to the backbone is lengthy and hydrophobic, and its terminus is a complicated guanidinium group. The compound is mildly soluble in ethanol but insoluble in ethyl ether. With a pKa of 2.24, it is highly alkaline. NIH 2018
Utilization and Pharmacology
L-arginine is categorized as a non-essential amino acid, however it may be regarded necessary or semi-essential during times of stress when the capacity for endogenous arginine synthesis is surpassed, such as during periods of growth (e.g., childhood, pregnancy) or trauma (eg, liver disease, severe sepsis, wound healing, cancer).
Morris 2017, Rodríguez 2008, Wu 2009 Normal L-arginine serum concentrations range between 50 and 150 mcM. Rodríguez 2008 Vegetarians may be at risk for arginine shortage because the majority of arginine in the average American diet comes from meat and fish, which offer roughly 5.5 g daily. Cheng 2001 suggests the following metabolic and physiologic functions of L-arginine in the body: building block of proteins; precursor of nitric oxide; induction of vasodilation; synthesis of creatine; reduction in xanthine oxidase activity; induction of bone and tendon formation and skin epithelization; simulation of energy metabolism through maintenance of adenosine triphosphate levels; simulation of growth hormone and prolactin release; simulation of insul Hristina 2014 L-arginine is also essential for the elimination of ammonia from the body. Calabrò 2014
Many animal and human cells produce nitric oxide, which is involved in numerous physiological and pathological processes. Luiking L-arginine is a substrate for four enzymes as of the year 2010: nitric oxide synthases, arginases, arginine glycine amidinotransferase, and L-arginine decarboxylase. Nitric oxide and L-citrulline are produced from L-arginine metabolism by nitric oxide synthase enzymes, according to Rodrguez (2008). Rodríguez 2008, Schwedhelm Arginases convert L-arginine to L-ornithine and urea in 2008. Morris 2017, Rodríguez After oral ingestion, L-arginine is eliminated presystemically (through GI flora) and systemically (by gut and liver arginases). Schwedhelm 2008 The majority of studies support the stereospecificity of nitric oxide synthase for L-arginine. However, trial results in steroid-naive patients with asthma indicate comparable concentrations of exhaled nitric oxide when either L- or D-arginine is administered, suggesting an alternative mechanism of action.
L-arginine is a necessary amino acid for the survival of certain parasites, such as Leishmania spp., the causative agent of leishmaniasis (Chambers, 2001). Wanasen 2008
The antiatherogenic, anti-ischemic, antiplatelet, and antithrombotic characteristics of L-arginine may have favourable impacts on cardiovascular health. Cheng, 2001,
Animal and in vitro Information
By preserving nitric oxide levels, increased L-arginine concentrations may benefit vascular disease.
Wascher 1996 Nitric oxide acted as a direct radical scavenger, reduced platelet adhesion and aggregation, and altered endothelial permeability. Brandes 2000, Wascher 1997 Nitric oxide regulated tissue factor in human microvascular endothelial cells, decreasing endotoxin- and cytokine-induced expression. Yang 2000
In a randomized clinical experiment aimed to examine the efficacy of oral L-arginine 9 g/day supplementation for 6 months after an acute ST-elevation myocardial infarction, there was no significant change in vascular stiffness or left ejection fraction. Unfortunately, 8.6% of patients in the L-arginine group died, whereas there were no deaths in the control group (P=0.01), and the study was halted. Researchers determined that L-arginine should not be administered to patients following an acute myocardial infarction and suggested that widespread atherosclerosis may worsen clinical outcome in elderly individuals. Schulman 2006
In a short trial of patients with native coronary artery disease, intramural infusion of L-arginine (6 mL of 100 mg/mL) significantly decreased neointimal volume compared to saline (25 mm³ vs. 39 mm³; P=0.049) after stent deployment. At the 6-month follow-up, individuals who received L-arginine had a considerably lower proportion of neointimal volume than those who got saline (17% [13%] vs 27% [21%]; P=0.048), indicating that L-arginine may be a viable strategy for the prevention of restenosis. Suzuki 2002
In individuals with 1- or 2-vessel coronary artery disease, intracoronary infusion of 150 mcmol/min L-arginine enhanced poststenotic coronary flow without affecting healthy arteries. In addition, the usage of angiotensin-converting enzyme inhibitors and an optimal lipid profile were related with a favorable response to L-arginine therapy. In another clinical research conducted by Lauer (2008), oral L-arginine treatment proved ineffective at increasing the bioavailability of nitric oxide in patients with coronary artery disease. Blum 2000 found that L-arginine supplementation increased exercise tolerance in angina patients. Ceremuzyński 1997
In one study, the ankle brachial index of 18 patients with chronic limb ischemia due to advanced peripheral arterial disease who underwent implantation of autologous bone marrow cells and daily administration of antioxidants and L-arginine for 6 weeks showed improvement at 3 and 12 months posttreatment. There was also an improvement in ischemic ulcers in thirteen of the eighteen patients; nevertheless, two patients required amputation of the ischemic leg. The mean maximum walking distance rose significantly at three months and was maintained until the end of the study period. Napoli A 41-year-old lady with a 35-year history of type 1 diabetes and exertional angina pectoris was diagnosed with microvascular angina in 2008
And began L-arginine supplementation with two nutritional bars containing 3.3 g of L-arginine per day. The patient reported an end to her angina attacks and an enhancement in her activity ability. Due to supplement supply concerns, L-arginine supplementation was replaced with atorvastatin 40 mg daily after eight weeks of treatment. During a week, the patient’s angina bouts returned, and after eight weeks, her activity capacity deteriorated. Restarting the L-arginine supplement resulted in the eradication of her angina symptoms, suggesting that L-arginine supplementation deserves further investigation as a viable therapy option for diabetes patients with microvascular angina. Schwartz 2003
In a trial of individuals with coronary artery disease, angina pectoris functional class IV, and prior revascularization who were receiving maximal medical therapy, L-arginine 9 g/day orally for 3 months improved angina pectoris functional class (from IV to II) in seven out of ten patients. After L-arginine was discontinued, symptoms returned to functional class IV. Blum 1999
In a 2X2 factorial design, patients who underwent coronary artery bypass grafting were randomized to receive either ten 200 mcg injections of vascular endothelial growth factor (VEGF)-165 plasmid DNA or placebo in the anterior myocardium, with oral L-arginine 6 g/day or placebo for three months. At three months, the combination of VEGF-165 and L-arginine was linked with better anterior wall perfusion relative to baseline. Ruel 2008
An intracoronary infusion of L-arginine (3,200 mcmol over 10 minutes) enhanced endothelium-dependent vascular relaxation (defined as peak coronary blood flow) to a greater extent in black patients without coronary artery disease than in matched white subjects, indicating that L-arginine supplementation may offer cardiovascular benefits in certain populations.
The year 2002 according to Houghton.
Supplementation with 700 mg of L-arginine four times daily prevented nitrate tolerance when nitroglycerin was administered transdermally continuously. Four and twenty-four hours after nitroglycerin patch administration, treadmill walking time rose significantly more than placebo (P0<05). Parker 2002
The National Heart, Lung, and Blood Institute paid for the Nitric Oxide in Peripheral Arterial Insufficiency (NO-PAIN) prospective, single-center, randomized, double-blind, placebo-controlled study. It is the largest study done so far to look at how L-arginine affects functional capacity in people with peripheral artery disease. 133 people with intermittent claudication were given either 3 grams of L-arginine by mouth every day or a placebo for 6 months. Those who took supplements had much higher levels of L-arginine in their blood. Even though absolute claudication distance got better for those who took L-arginine for a long time (mean improvement of 11.5%), it got better by a lot more for those who took a placebo (28.3%; P=0.024), which suggests that long-term treatment has a bad effect. This may be because arginine messes up the nitric oxide synthase pathway, which leads to a paradoxical drop in the production of nitric oxide. Wilson 2007
Showed that L-arginine made the hearts of people with severe congestive heart failure work better (CHF) Bednarz 2004, Bocchi 2000, and Wascher 1997. However, in one study of CHF patients who took L-arginine supplements, all hemodynamic variables stayed the same. In the same study, healthy controls who took L-arginine had their stroke volume and cardiac index go up. Piccirillo 2004 When given with losartan 50 mg for 2 days in a row to 9 patients with stable New York Heart Association class II or III heart failure, L-arginine 20 g IV (after the second dose of losartan) improved cardiac index and stroke volume compared to losartan alone. Koifman 2006
Low-dose L-arginine-rich blood showed a protective effect in ischemia/reperfusion injury, with less perioperative myocardial infarction and shorter stays in the intensive care unit and hospital. Kiziltepe 2004
In men with high blood pressure and type 2 diabetes, taking 1,200 mg of L-arginine and 600 mg of N-acetylcysteine twice a day for 6 months improved endothelial function by making it easier for the body to use nitric oxide. In particular, the combination decreased systolic (P<0.05) and diastolic (P<0.05) mean arterial blood pressure, total cholesterol (P<0.01), low-density lipoprotein cholesterol (P<0.005), and high-sensitivity C-reactive protein (P<0.05). It also increased high-density lipoprotein levels (P<0.05) and improved intima-media thickness during endothelial postischemic vasodilation (P<0.02). Martina 2008
Statins have been shown to make nitric oxide synthase make more of itself. The levels of asymmetric dimethylarginine (ADMA), an inhibitor of nitric oxide synthase, were checked in 98 older people, and then they were given either simvastatin 40 mg/day, oral L-arginine 3 g/day, or a combination therapy for 3 weeks. Subjects with high levels of ADMA were not affected by endothelium-dependent vasodilation when they only took simvastatin. Even though L-arginine on its own was linked to improvements in endothelium-dependent vasodilation, combination therapy had a bigger effect. People with low ADMA levels had better endothelial function when they took simvastatin alone, L-arginine alone, or both. Böger 2007
Cigarette smoking causes more white blood cells to stick to endothelial cells and is linked to problems with how endothelial cells work. In one study, smokers had more adhesion between monocytes and endothelial cells than nonsmokers (46.4% [4.5%] vs. 27% [5.2%]; P<0.001). After 7 grams of L-arginine were taken by mouth, smokers’ monocyte/endothelial cell adhesion dropped to 35.1% (4%) (P=0.002). Vitamin C was not found to be reversible. Adams 1997
In many diseases, arginase levels are high, which stops the body from making nitric oxide. Researchers have suggested that the “global arginine bioavailability ratio” (GABR, which is defined as arginine/[ornithine+citrulline]) is a better way to predict the development and progression of major adverse cardiovascular events than arginine levels alone. In a study of plasma samples from 1,010 patients, those with obstructive coronary artery disease had lower levels of plasma arginine but higher levels of plasma ornithine and citrulline. This made the median GABR levels lower. Even after taking into account risk factors, high-sensitivity C-reactive protein, and creatinine clearance, GABR was still linked to obstructive coronary artery disease. Tang 2009
A meta-analysis of 11 double-blind, randomized, placebo-controlled trials (N=387) that looked at the effects of L-arginine on blood pressure in people with and without different health conditions (like high cholesterol, type 2 diabetes, coronary artery disease, and polycystic ovary syndrome), most of whom were normotensive, found that systolic and diastolic blood pressure dropped by 5.39 mm Hg and 2.66 mm Hg, There was a lot of difference between them. In studies, groups of 12 to 79 people took L-arginine orally at doses of 4 to 24 g/day (the average was 9 g/day) for 2 to 24 weeks (median, 4 weeks). When sensitivity analyses were done, none of the individual studies seemed to have had a big effect on the overall combined effect sizes. Dong 2011
The American College of Cardiology Foundation/American Heart Association Guideline for the Management of Peripheral Arterial Disease (2005/2011) says that it is not clear if L-arginine helps people with intermittent claudication (level B evidence). Anderson 2013
The disease Cystic Fibrosis
In people with cystic fibrosis, a lack of nitric oxide in the airways may make it hard for them to breathe. In a clinical study, nebulized L-arginine (18 mL of a 7% solution containing L-arginine 1.3 g) given to patients with cystic fibrosis was compared with a saline (placebo) solution given to healthy controls. Fractional exhaled nitric oxide (FENO; single-breath online measurements of lower airway nitric oxide done at a constant expiratory flow of 50 mL/min) showed that inhaled L-arginine was linked to higher levels of nitric oxide (P<0.0001). After inhaling L-arginine for 4 hours, there was a significant increase in the mean forced expiratory volume in the first second (FEV1) (P<0.0005). No change in forced vital capacity was noted. After inhalation, FENO in patients who were given nebulized saline showed a small but statistically significant improvement, but FEV1 went down. Nebulized L-arginine may be a way to help people with cystic fibrosis improve their lung function, but more research is needed. Grasemann 2006
Animal and in vitro data
Streptozotocin made rats diabetic, and when they ate L-arginine, their nerve pain got better. But L-arginine did not have any effect on glucose levels, eating a lot, or losing weight. Rondon 2017
L-arginine administration stimulates insulin secretion and enhances insulin-mediated glucose disposal, with various mechanisms suggested, including beta-cells in the pancreas take up positively charged L-arginine molecules, resulting in plasma membrane depolarization; metabolism of L-arginine by arginase yields ornithine and urea; and nitric oxide is produced from L-arginine by the enzyme nitric oxide synthase.
Cheng 2001, Tsai 2009 In one study, patients with type 2 diabetes who took 9 grams of L-arginine orally every day for a month had better insulin sensitivity in their peripheral and liver cells. No changes in body weight, glycated hemoglobin, serum potassium, diastolic blood pressure, or heart rate were demonstrated. In the L-arginine group, the systolic blood pressure went down. Piatti in 2001
In study of 144 middle-aged people with poor glucose tolerance and metabolic syndrome were given 6.4 g of L-arginine or a placebo by mouth every day for 18 months. After 18 months, the patients were followed for another 90 months to find out how often diabetes would happen in the long run. At the end of this 9-year period, there were no differences in the chances of getting diabetes. However, 40.6% of the people in the L-arginine group got diabetes, while 57.4% of the people in the placebo group did. This led to an adjusted risk ratio for diabetes (L-arginine vs. placebo) of 0.66 (95% CI, 0.48 to 0.91; P<0.02). Monti 2017
In a study of the vasodilator effects of L-arginine, coinfusion with insulin enhanced the potency of arginine, with increases in renal and ocular hemodynamic parameters observed. Dallinger 2003
Diabetes patients have low levels of L-arginine and high levels of asymmetric dimethylarginine, which slows down the process of making nitric oxide. In a double-blind, vehicle-controlled, two-period, crossover pilot study, the effectiveness of a cream with 4 mg/cm² of L-arginine on improving blood flow to the feet was tested. The topical preparation improved both flow and temperature in the feet. At first, the study was going to look at the effects after a one-week washout period, but this was found to be too short (i.e., the effect of L-arginine persisted throughout the washout period). The protocol was changed so that the effects of giving L-arginine over time could be measured. This new way of making L-arginine could be a way to treat diabetes by improving blood flow and, in the long run, reducing the microvascular problems that come with the disease. Fossel 2004 In another clinical study, 8 of 11 (73%) diabetic ulcer patients who got L-arginine 10 mM subcutaneously at the wound site healed completely. The other three patients also got better, but they had to leave the study because they were moving. Arana 2004
In a study of healthy male athletes, 0.1 g/kg of arginine powder (L-arginine 45.5%) in 150 mL of water raised glucose and insulin levels 15 and 30 minutes after exercise. During the 30-minute and 45-minute recovery periods after exercise, the level of free fatty acids went down. Tsai 2009
The Endothelium Dysfunction
Endothelial function was looked at in a study of people with acute leukemia who took L-arginine supplements. Patients either got chemotherapy with anthracycline antibiotics (control group) or chemotherapy with anthracycline antibiotics plus a L-arginine IV infusion the day before and during anthracycline antibiotic administration, followed by L-arginine aspartate 5 mL three times a day for one month. L-arginine made the endothelium work better and boosted the activities of superoxide dismutase and total nitric oxide synthase. Skrypnyk 2017
Erectile TISSUE And FUNCTION
Animal and in vitro data
Nitric oxide needs to be made by L-arginine in order for smooth cavernous muscle in the penis to relax. This suggests that L-arginine may play a role in erectile dysfunction. Studies on rats found that they got an erection and that the tone of their blood vessels changed. Bivalacqua 2000 Daily L-arginine dosed at 0.65 g/kg was found to be effective in preventing radiation-induced damage to penile structures in rats. Medeiros 2014
In a controlled crossover study with men who had impotence, there was no difference between taking 500 mg of L-arginine three times a day orally and taking a placebo. Klotz 1999
L-arginine has been studied in combination with the standard of care, oral type-5 phosphodiesterase (PDE-5) inhibitors, for erectile dysfunction. Men with diabetes and erectile dysfunction were given a mix of L-arginine, nicotinic acid, and propionyl-L-carnitine (PLC) with and without the PDE-5 inhibitor vardenafil. The International Index of Erectile Function (IIEF) showed that those who took L-arginine, nicotinic acid, and PLC had better erectile function by 2 points. The IIEF score went up by 4 points in the group that only got vardenafil, and it went up by 5 points in the group that also got L-arginine, nicotinic acid, and PLC along with vardenafil. Those who were given a placebo did not get better over time. Gentile 2009 In another study, when men who didn’t respond to tadalafil 20 mg were given L-arginine 600 mg/day as an add-on therapy, their answers to two IIEF questions about their ability to get and keep an erection long enough for sexual activity got better. Cumpanas 2009
In a small (N=9) randomized, double-blind, crossover study, the effect of L-arginine supplementation on exercise performance was looked at. The men in the study ranged in age from 19 to 38 years. A 500 mL solution with 6 g of L-arginine or a placebo was given by mouth an hour before the monitored cycling machine sessions. The active and placebo treatments were separated by a 10-day washout period. When comparing L-arginine to placebo, significantly different mean ( standard deviation) values were seen for plasma nitrite levels (331198 nM vs. 159102 nM; P<0.05), systolic blood pressure (1233 mm Hg vs. 1315 mm Hg; P<0.01), and steady-state oxygen uptake (VO₂) during moderate-intensity exercise (1.480.12 L/min VO₂ slow component amplitude reduction (0.580.23 L/min vs. 0.760.29 L/min; P<0.05) and time to exhaustion (707232 seconds vs. 562145 seconds; P<0.05) were significantly better for L-arginine during severe-intensity exercise. Bailey 2010
Nutritional or Metabolic or Immunostimulatory action
Animal and in vitro data
When given to rats with jaundice, L-arginine had anabolic and immune-stimulating effects.
Kennedy 1994 It has been linked to faster healing of bone (when combined with inositol and silicon), burns, the GI tract, and tendons. It has also been linked to faster healing of pressure ulcers. Curtis in 2016, Drmic in 2017, Hristina in 2014, and Yaman in 2016
In a randomized clinical trial with people who had tuberculosis, adding arginine to chemotherapy made C-reactive protein levels and general symptoms go down after the first month of treatment. Also, after the first and second months of treatment with arginine, the body mass index (BMI) got better. Farazi 2015
When arginine-enhanced enteral nutrition was given to malnourished patients with head and neck cancer, there were fewer fistulas, shorter hospital stays, and a trend toward better survival. However, other trials were unable to show a positive clinical outcome.
De Luis 2005, De Luis 2015, van Bokhorst 2001 In a study of people who had surgery for esophageal cancer, L-arginine given by mouth as part of an immuno-enhanced diet with omega-3 fatty acids and RNA stopped the drop in platelets after surgery and lowered prothrombin activity and thrombin-antithrombin III complex levels. Also, the number of T-cells was higher in patients who took this enteral product on days 1 and 7 after surgery. So, a diet that boosts the immune system and includes L-arginine may be helpful after surgery for esophageal cancer to lower the risk of getting sick. Aiko 2008
In a randomized, double-blind pilot study, the effectiveness of L-arginine 36.2 g given by mouth was compared to that of a placebo (alanine 51.2 g) in people who were getting skin transplants as part of reconstructive surgery. When it came to angiogenesis, reepithelialization, and neutrophil count, there were no differences between the two treatment groups. Most of the patients found it hard to drink the solutions because they tasted bad, which may have changed the results given the small number of people in the study. Debats 2009 In a study done by the same researchers, IV arginine gave the same results, and there were no improvements in how quickly human skin graft donor sites healed. Debats 2011
Two randomized clinical trials that looked at the use of arginine in premature babies were found in a review of the scientific literature. Supplementing with arginine lowered the risk of necrotizing enterocolitis. This effect is thought to be caused by lower levels of nitric oxide and hypoxic-ischemic injury, which makes the mesenteric vascular resistance go up. Mitchell 2014 In these studies, arginine supplementation cut the risk of stage II and III necrotizing enterocolitis by 59% compared to a placebo (relative risk [RR], 0.41; 95% confidence interval [CI], 0.2 to 0.85; P<0.02). Also, all stages of necrotizing enterocolitis were 60% less common in people who took arginine (RR, 0.4; 95% CI, 0.23 to 0.69; P=0.001). At age 3, there were no big differences between the groups in terms of neurodevelopmental disabilities. Mitchell 2014 In another review that looked at 3 trials of arginine supplementation in neonates with necrotizing enterocolitis, the risk of stage I (RR, 0.37 [95% CI, 0.15 to 0.9]) and stage III (RR, 0.13 [95% CI, 0.02 to 1.03]) necrotizing enterocolitis was significantly lower in the arginine group than in the control group. Arginine didn’t cause any bad effects, like low blood pressure or changes in how glucose stays in the body. Shah 2017
Animal and in vitro data
L-arginine caused the posterior ciliary arteries of both rabbits and humans to relax in a way that depended on the concentration. Chuman 2017
In a randomized clinical trial that looked at the effects of giving healthy adults an infusion of 1 g/min of arginine for 30 minutes, the mean arterial pressure went down and the blood flow to the retina and choroid went up. The effects were still there 30 minutes after the infusion stopped, which suggests that arginine could help with eye diseases like diabetes or glaucoma that are linked to endothelial dysfunction. Garhöfer 2005
In a randomized clinical trial with pregnant women who had high blood pressure, an infusion of 20 g of arginine per 500 mL lowered both the systolic and diastolic blood pressure. The heart rate of the fetus was not changed. Neri 2004 In another study, women with preeclampsia who took 12 g/day of arginine by mouth for two days had no change in their mean diastolic blood pressure. Staff 2004
Animal and in vitro data
Rats with renal ischemia/reperfusion injury had less kidney damage when they were given 300 mcg/kg/min IV of L-arginine. Tong 2017
Bennett-Richards (2002) found that giving arginine to children with chronic renal failure did not improve endothelial dysfunction, and it did not protect adults with chronic renal failure from nephrotoxicity caused by contrast media. Miller 2003
Nitric oxide levels may go up in people with decompensated cirrhosis, which can cause their kidney function to get worse over time. In a prospective study done by a group of researchers, plasma levels of nitric oxide and L-arginine went up as renal function got worse. Both levels were higher in patients with hepatorenal syndrome type II. Kayali 2009
Sickle cell disease
Sickle cell disease is a lack of the amino acid arginine. In people with sickle cell disease, neutrophils that release harmful substances damage endothelial cells and make them work harder. Neutrophils cause blood vessels to close off and damage to tissues. Nitric oxide is broken down in part by the superoxide anion that endothelial cells and neutrophils give off. In a state where these cells don’t have enough L-arginine, they make more superoxide anion. Patients with sickle cell disease have a lack of L-arginine because of too much arginase activity, according to Gladwin 2003, Morris 2005, and Waugh 2001. Morris 2017
In a clinical study with 5 people who had sickle cell disease, giving them 0.1 g/kg of the L-arginine precursor L-citrulline twice a day made them feel better. Supplementation was also linked to higher levels of the amino acid arginine and lower counts of both total leukocytes and segmented neutrophils. Continuous L-citrulline therapy kept the number of white blood cells and neutrophils at lower levels. Waugh 2001
In a randomized, placebo-controlled trial, 38 sickle cell disease patients who were in the hospital for vasoocclusive crises were given L-arginine 100 mg/kg three times a day by IV or mouth, or a placebo, for 5 days or until they were released. In the group that got L-arginine, the total amount of opioids given through a vein was cut by 54%, and pain scores at discharge were lower. Supplementation didn’t have a big effect on how long people stayed in the hospital, but there was a trend in favour of treatment. Morris 2013
Ten people with sickle cell disease and pulmonary hypertension (mean age 32.715 years) who took L-arginine by mouth three times a day for five days saw their pulmonary artery systolic pressure drop by 15.2% (from 63.913 mm Hg to 54.212 mm Hg; P=0.002). Follow-up echocardiography at 1 month showed that 4 of the 9 compliant patients went back to their baseline pulmonary artery systolic pressure values, 1 patient got worse and was admitted for acute chest syndrome, and 4 patients kept getting better. Two of the patients who got better started on transfusion therapy, and one of them kept getting L-arginine therapy at 0.1 g/kg twice a day. Smith 2003
Patients with sickle cell disease were given either 0.1 to 0.2 g/kg of L-arginine three times a day or 25 to 100 mg of sildenafil three times a day. The effects on safety, cardiopulmonary function, and fetal hemoglobin were measured. L-arginine did not improve pulmonary pressure or the distance a person could walk in 6 minutes. Sildenafil, on the other hand, did. But fetal hemoglobin levels dropped by 2.9% (16.1%) from baseline in patients who took L-arginine, while fetal hemoglobin levels rose in patients who took sildenafil. Little 2009
Animal and in vitro data
Rats given L-arginine by IV at doses between 50 and 250 mg/kg were more likely to live through heatstroke (54 to 245 minutes). In particular, L-arginine lowered intracranial hypertension and raised levels of a metabolite of nitric oxide in the hypothalamus. Chen 2008 Clinical data
A Cochrane review of randomized clinical trials found that there isn’t enough evidence about the effects of nitric oxide donors, L-arginine, or nitric oxide synthase inhibitors to recommend their use in acute ischemic stroke. The only drug that has been looked at is glyceryl trinitrate. In people who have just had a stroke, glyceryl trinitrate lowers blood pressure, speeds up the heart rate, and gives them headaches, but it doesn’t change the clinical results (high-quality evidence). Bath 2017
High levels of nitric oxide are thought to be harmful to brain tissue.Bath 2017
In a clinical trial that looked at intrauterine growth restriction therapy, giving L-arginine 3 g/day orally for 20 days made newborn babies heavier than if nothing was done.
Sieroszewski 2004: L-arginine helped some people who had overdosed on valproate and also had a condition called hyperammonemia. Schrettl 2017
L-arginine has been studied for a number of conditions using different doses and lengths of treatment (up to 18 months). The most common daily doses range from 6 to 30 g taken orally in 3 separate doses.
Morris in 2017 Most of the research has been done on oral and intravenous forms. Oral L-arginine supplementation is limited by how L-arginine is taken up by the GI tract and liver, as well as the risk of GI distress, which often depends on the dose. So, L-citrulline supplements could be used to boost L-arginine levels and make nitric oxide more bioavailable. Allerton 2018
Pregnancy and Breastfeeding
A systematic review of the research (N=884 women) found that pregnant women with high blood pressure or who were thought to be at risk for preeclampsia who took L-arginine supplements were less likely to get preeclampsia.
Dorniak-2014 Wall’s Since there isn’t much known about the safety and effectiveness of L-arginine during pregnancy and breastfeeding, it should only be used in these situations if a health care provider tells you to and you’re under their care.
Nitrates: Patients who take both L-arginine supplements and nitrates need to be careful. L-arginine may make the effects of isosorbide mononitrate and other nitric oxide donors, like nitroglycerin and sodium nitroprusside, stronger. Stokes 2003
Insulin: People who take insulin and L-arginine together should be careful because the effects on insulin are hard to predict.
Cholesterol-lowering drugs: Patients who take cholesterol-lowering drugs along with L-arginine should be careful because the effects of cholesterol-lowering drugs are hard to predict.
Fleischmann 2002, Piatti 2001
There have been reports of nausea, diarrhea, dyspepsia, palpitations, headaches, and feeling numb. Morris, 2017. Enteral arginine supplementation was linked to diarrhea in a study of malnourished people with head and neck cancer.
De Luis 2015 In a study evaluating effects of L-arginine 9 g/day over 6 months on exercise capacity in patients with stable angina pectoris, no adverse reactions were reported. Ceremuzyński 1997 Higher doses may be associated with a bitter taste that may affect patient compliance.
Chagan 2002 Due to L-vasodilatory arginine’s properties, hypotension may occur. IV preparations with L-arginine hydrochloride have a lot of chloride, which could be dangerous for patients with electrolyte imbalances. The acidity of L-arginine can cause metabolic acidosis, which is a sudden drop in blood pH that has been linked to arrhythmias.
Hyperkalemia can happen when intracellular potassium is moved out of cells. This can happen in people with liver and/or kidney problems who are being treated with L-arginine. Because of a decreased ability to get rid of urea, L-arginine therapy may cause BUN and urea to rise in people with kidney disease. Böger 2001
High levels of nitric oxide are thought to be harmful to brain tissue.
Bath 2017 A 21-month-old girl who was being tested for a lack of growth hormone got too much L-arginine by accident. She went into cardiopulmonary arrest, and 36 hours after her heart and lungs were brought back to life, she died from myelinolysis. Gerard 1997
This information relates to a herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product.
This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is just a short summary of some general facts about this product. It does NOT tell you everything you need to know about this product’s possible uses, directions, warnings, precautions, interactions, bad effects, or risks.
This is not specific medical advice, and it doesn’t replace the information you get from your doctor. Talk to your health care provider to find out everything you need to know about the risks and benefits of using this product.
This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. Before surgery or any other medical procedure, it is important to tell your doctor about any herbal, vitamin, mineral, or other supplement you are taking.
Except for the use of folic acid and prenatal vitamins during pregnancy, which are generally thought to be safe in normal amounts, this product has not been studied enough to know if it is safe to use during pregnancy, while nursing, or by people younger than 2 years old.
Tools for professionals
Related treatment guides
• Dietary Supplementation
• Diagnosis and Investigation
Adams, M.R., W. Jessup, and D.S. Celermajer. Human monocytes stick to endothelial cells more when people smoke cigarettes. This effect can be reversed with oral L-arginine, but not with Vitamin C. J Am Coll Cardiol. 1997;29(3):491-497.9060883
Aiko S, Yoshizumi Y, Ishizuka T, et al. Enteral immune-enhanced diets with arginine are safe and helpful for people who have just had surgery for esophageal cancer. Dis Esophagus. 2008;21(7):619-627.18459991
TD Allerton, DN Proctor, JM Stephens, TR Dugas, G Spielmann, BA Irving. Effects of taking L-citrulline supplements on cardiometabolic health. Nutrients. 2018;10(7).3002948210.3390/nu10070921
Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease: a report from the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. This report is a compilation of the 2005 and 2011 ACCF/AHA guideline recommendations. 2013;127(13):1425–1443.
Arana V, Paz Y, González A, Méndez V, Méndez JD. Patients who took L-arginine saw their diabetic foot ulcers heal. 2004;58(10):588-597.15589068
PubChem is an open database for chemistry. Website for the National Institutes of Health. https://pubchem.ncbi.nlm.nih.gov/compound/L-arginine#section=Top. Last changed on October 6, 2018. Accessible as of 8 October 2018.
Bailey SJ, Winyard PG, Vanhatalo A, et al. Acute L-arginine supplementation reduces the O2 cost of moderate-intensity exercise and enhances high-intensity exercise tolerance. J Appl Physiol (1985). (1985). 2010;109(5):1394-1403.20724562
Bath PM, Krishnan K, Appleton JP. Nitrates, L-arginine, or nitric oxide synthase inhibitors are used to treat a sudden stroke. Cochrane Database Syst Rev. 2017;4:CD000398.28429459
Bednarz B, Jaxa-Chamiec T, Gebalska J, Herbaczyńska-Cedro K, Ceremuzyński L. Supplementing with L-arginine makes it possible for people with congestive heart failure to work out for longer. Kardiol Pol. 2004;60(4):348-353.15226784
Bennett-Richards KJ, Kattenhorn M, Donald AE, et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. 2002;62(4):1372-1378.12234308 Kidney International
Bivalacqua TJ, Diner EK, Novak TE, et al. A rat model of Peyronie’s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol. 2000;163(6):1992-1998.10799245
A. Blum, L. Hathaway, R. Mincemoyer, and many others. Oral L-arginine in patients with coronary artery disease on medical management. Circulation. 2000;101(18):2160-2164.10801756
Blum A, Porat R, Rosenschein U, et al. Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris. Am J Cardiol. 1999;83(10):1488-1490, A8.10335768
Bocchi EA, Vilella de Moraes AV, Esteves-Filho A, et al. L-arginine slows down the heart rate and makes the blood flow better in people with severe congestive heart failure. Clin Cardiol. 2000;23(3):205-210.10761810
Boger GI, Rudolph TK, Maas R, et al. The effect of combining simvastatin with oral L-arginine on the improvement of endothelium-dependent vasodilation by dimethylarginine. J Am Coll Cardiol. 2007;49(23):2274-2282.17560293
Böger RH, Bode-Böger SM. The effects of L-arginine on the body. Annu Rev Pharmacol Toxicol. 2001;41:79-99.11264451
Brandes RP, Brandes S, Böger RH, Bode-Böger SM, Mügge A. When rabbits with high cholesterol are given L-arginine, the adhesion of white blood cells to the non-endothelial matrix returns to normal. Life Sci. 2000;66(16):1519-1524.10794499
Budavari S, ed. The Merck Index. 11th ed. Rahway, NJ: Merck and Co; 1989:123.
L-arginine and vascular diseases: lights and pitfalls! Calabr RS, Gervasi G, Bramanti P. Acta Biomed. 2014;85(3):222-228.25567458
Ceremuzyński L, Chamiec T, Herbaczyńska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol. 1997;80(3):331-333.9264427
Chagan L, Ioselovich A, Asherova L, Cheng JW. Use of alternative pharmacotherapy in management of cardiovascular diseases. Am J Manag Care. 2002;8(3):270-285.11924555
Chambers DC, Ayres JG. Effect of nebulized L- and D-arginine on exhaled nitric oxide in steroid-naive asthma. Thorax. 2001;56(8):602-606.11462061
Chen YC, Liu YC, Yen DH, et al. L-arginine causes amelioration of cerebrovascular dysfunction and brain inflammation during experimental heatstroke. Shock. 2008;29(2):212-216.17693925
Cheng JW, Baldwin SN. L-arginine in the management of cardiovascular diseases [published correction appears in Ann Pharmacother. 2001;35(7-8):965]. Ann Pharmacother. 2001;35(6):755-764.11408995
Chuman H, Sugimoto T, Nao-I N. L-arginine had a relaxing effect on isolated rabbit and human posterior ciliary arteries in vitro and increased blood flow to the optic disc in vivo. Graefes Arch Clin 2017 Dec;255(12):2381–2388.29063193 Exp Ophthalmol.
Cumpanas A, Botoca M, Minciu R, Fahes M, Bucuras V, Miclea F. Can adding L-arginine to tadalafil help people with erectile dysfunction who don’t get better with tadalafil alone? Urology. 2009;74(4)(suppl):S330.
Curtis L. Tendon injuries might be easier to treat if more is known about nutrition. Nutrition. 2016;32(6):617-619.26921066
Dallinger S, Sieder A, Strametz J, Bayerle-Eder M, Wolzt M, Schmetterer L. Insulin makes the effects of L-arginine on the blood vessels wider in humans. Am J Physiol Endocrinol Metab. 2003;284(6):E1106-E1111.12736155
Debats IB, Booi DI, Wehrens KM, et al. Oral arginine supplements and the effect on skin graft donor sites: a randomized clinical pilot study. 2009;30(3):417–426.19349894
Debats IB, Koeneman MM, Booi DI, Bekers O, van der Hulst RR. Intravenous arginine and the healing of human skin graft donor sites: a randomized controlled trial. Burns. 2011;37(3):420-426.21087825
De Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC. A randomized clinical trial with oral Immunonutrition (omega3-enhanced formula vs. arginine-enhanced formula) in head and neck cancer patients who can move around. Ann Nutr Metab. 2005;49(2):95-99.15802904
De Luis DA, Izaola O, Terroba MC, Cuellar L, Ventosa M, Martin T. Effect of three different doses of arginine-enhanced enteral nutrition on nutritional status and outcomes in well-nourished cancer patients after surgery: a randomized single-blinded prospective trial. 2015;19(6):950-955.25855918
Dong JY, Qin LQ, Zhang Z, et al. A meta-analysis of randomized, double-blind, placebo-controlled trials looked at the effect of taking L-arginine by mouth on blood pressure. Am Heart Journal. 2011;162(6):959–965.
Dorniak-Wall T, Grivell RM, Dekker GA, Hague W, Dodd JM. The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens. 2014;28(4):230-235.24172291
Drmic D, Kolenc D, Ilic S, et al. Rats who took celecoxib got damage to their intestines, liver, and brains. BPC 157 or L-arginine helped stop this damage, while L-NAME made it worse. World Journal of Gastroenterology. 2017;23(29):5304-5312.28839430
Farazi A, Shafaat O, Sofian M, Kahbazi M. Adding arginine to treatment for active tuberculosis. Tuberc Res Treat. 2015;2015:205016.25734013
Fleischmann EH, Schlaich MP, Schmidt BM, Oehmer S, Schmieder RE. Changes in kidney blood flow caused by L-arginine are not affected by high cholesterol or treatment with statins. Nephrol Dial Transplant. 2002 Oct;17(10):1758-1765.12270981
Fossel ET. A pilot study found that a transdermal preparation of L-arginine made the feet of people with diabetes warmer and the blood flow better. Diabetes Care. 2004;27(1):284-285.14694013
Garhofer G, Resch H, Lung S, Weigert G, Schmetterer L. Intravenous administration of L-arginine increases retinal and choroidal blood flow. 2005;140(1):69–76.15953576
Gentile V, Antonini G, Antonella Bertozzi M, et al. Effect of propionyl-L-carnitine, L-arginine, and nicotinic acid on the effectiveness of vardenafil in treating erectile dysfunction in diabetics. Curr Med Res Opin. 2009;25(9):2223-2228.19624286
Gerard JM, Luisiri A. A dose of arginine hydrochloride that killed the person. J Toxicol Clin Toxicol. 1997;35(6):621-625.9365430
Gladwin MT, Schechter AN, Ognibene FP, et al. Different ways for men and women with sickle cell disease to use nitric oxide. Circulation. 2003;107(2):271-278.12538427
Grasemann H, Kurtz F, Ratjen F. When cystic fibrosis patients breathe in L-arginine, it makes their exhaled nitric oxide and pulmonary function better. Am J. Respir. Critical Care Med. 2006;174(2):208–212.16627863
Houghton JL, Philbin EF, Strogatz DS, et al. African Americans are more likely to have better coronary endothelial function after getting more L-arginine. J Am Coll Cardiol. 2002;39(8):1314-1322.11955849
Hristina K, Trapecar M, Langerholc T. L-arginine has new roles in the body’s energy metabolism and may have clinical applications. 2014;18(2):213–218.24522477
Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with worsening renal dysfunction. Kayali Z, Herring J, Baron P, et al. J Gastroenterol Hepatol. 2009;24(6):1030-1037.19226382
JA Kennedy, SJ Kirk, DC McCrory, MI Halliday, GR Barclay, BJ Rowlands. Modulation of immune function and weight loss by L-arginine in obstructive jaundice in the rat. Br J Surg. 1994;81(8):1199-1201.7953359
Kiziltepe U, Tunçtan B, Eyileten ZB, et al. The effectiveness of L-arginine-enhanced cardioplegia and reperfusion without cardioplegia in ischemic hearts. Int J Cardiol. 2004;97(1):93-100.15336814
Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. A controlled crossover study looked at how well oral L-arginine worked as a first-line treatment for impotence. 1999;63(4):220–223.10743698 Urol International
Koifman B, Topilski I, Megidish R, et al. Effects of losartan and L-arginine on making nitric oxide, how endothelial cells work, and how blood flows in people with heart failure caused by coronary heart disease. Am J Cardiol. 2006;98(2):172-177.16828587
Lauer T, Kleinbongard P, Rath J, Schulz R, Kelm M, Rassaf T. L-arginine widens stenotic parts of coronary arteries more than other parts. This increases coronary flow. J. Internal Medicine. 2008;264(3):237–244.
Little JA, Hauser KP, Martyr SE, et al. When people with sickle cell disease are taking hydroxyurea, adding L-arginine or blocking phosphodiesterase 5 has effects on their blood cells, biochemistry, and heart and lungs. Eur J Haematol. 2009;82(4):315-321.19215288
Liu P, Shen WQ, Chen HL. A systematic review was done on the effectiveness of arginine-rich enteral formulas for healing pressure ulcers. Journal of Wound Care. 2017;26(6):319–323.28598762
Luiking YC, Engelen MP, Deutz NE. Controlling how much nitric oxide is made in health and illness. Curr Opinion Clin Nutr Metab Care. 2010;13(1):97-104.19841582
Martina V, Masha A, Gigliardi VR, et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care. 2008;31(5):940-944.18268065
McNeal C.J., Meininger C.J., D. Reddy, C.D. Wilborn, and G. Wu. How safe and helpful arginine is for adults. J Nutr. 2016;146(12):2587S-2593S.27934649
Medeiros JL Jr, Costa WS, Felix-Patricio B, Sampaio FJ, Cardoso LE. The protective effects of adding arginine and glutamine to a rat’s diet before it gets pelvic radiation on the penis. Andrology. 2014;2(6):943-950.25271133
Miller H.I., A. Dascalu, T.A. Rassin, Y. Wollman, T. Chernichowsky, and A. Iaina. Effects of a single dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial. 2003;23(2):91-95.12481147
Mitchell K, Lyttle A, Amin H, Shaireen H, Robertson HL, and Lodha AK. An updated systematic review of the use of arginine supplements to prevent necrotizing enterocolitis in premature babies. BMC Pediatr. 2014;14:226.25205007
Monti LD, Galluccio E, Villa V, Fontana B, Spadoni S, Piatti PM. Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study) [published online ahead of print October 20, 2017]. Eur J Nutr. 2017.2905276610.1007/s00394-017-1548-2
Morris CR, Hamilton-Reeves J, Martindale RG, Sarav M, and Ochoa Gautier JB. Acquired amino acid deficiencies: a focus on arginine and glutamine. Nutr Clin Pract. 2017;32(1)(suppl):30S-47S.28388380
Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81-90.15998894
Morris CR, Kuypers FA, Lavrisha L, et al. A randomized, placebo-controlled trial of arginine therapy to treat vaso-occlusive pain episodes in children with sickle cell disease who are in the hospital. Haematologica. 2013;98(9):1375-1382.23645695
CR Morris, SM Morris Jr., W Hagar, et al. Arginine therapy: a new way to treat high blood pressure in the lungs in people with sickle cell disease? Am J 2003;168(1):63–69.12626350 Respir Critical Care Med.
Napoli C, Farzati B, Sica V, et al. Positive effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia. Eur J Cardiovasc Prev Rehabil. 2008;15(6):709-718.19050436
Neri I, Blasi I, Facchinetti F. Effects of acute L-arginine infusion on non-stress test in hypertensive pregnant women. J Matern Fetal Neonatal Med. 2004;16(1):23-26.15370078
Ochiai M, Hayashi T, Morita M, et al. Short-term effects of supplementing with L-citrulline on the stiffness of the arteries in middle-aged men. 2012;155(2):257–261
Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH. The effect of extra L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
Piatti PM, Monti LD, Valsecchi G, et al. When type 2 diabetics take L-arginine by mouth for a long time, their peripheral and liver insulin sensitivity improves. Diabetes Care. 2001;24(5):875-880.11347747
Piccirillo G, Raffaele Q, Fimognari F, et al. Influence of L-arginine and vitamin C on the autonomic nervous system in chronic heart failure caused by ischemic cardiomyopathy. Am J Cardiol. 2004;93(5):650-654.14996603
Rodríguez PC, Ochoa AC. Control of arginine by myeloid-derived suppressor cells and tolerance in cancer: how it works and what it means for treatment. Immunol Rev. 2008;222:180-191.18364002
Rondón LJ, Farges MC, Davin N, et al. Allodynia and hyperalgesia can be prevented in painful diabetic neuropathic rats by giving them extra L-arginine. This is done by normalizing the level of nitric oxide in the blood and raising the level of agmatine in the blood. This research was published online ahead of print on July 19, 2017. Eur J Nutr. 2017.2872594210.1007/s00394-017-1508-x
Ruel M, Beanlands RS, Lortie M, et al. The Endothelial Modulation in Angiogenic Therapy randomized controlled trial found that patients with severe diffuse coronary artery disease benefited more from surgery when they also took oral L-arginine. J Thorac Cardiovasc Surg. 2008 Apr;135(4):762-770.18374753
Schrettl V, Felgenhauer N, Rabe C, Fernando M, Eyer F. L-arginine for treating valproate overdose: five clinical cases. Clin Toxicol (Phila). 2017;55(4):260-266.28152637
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. Schulman SP, Becker LC, Kass DA, et al. JAMA. 2006;295(1):58-64.16391217
Schwartz L. Arginine supplementation improves microvascular angina. Ann Intern Med. 2003;138(2):160.12529108
Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of orally administered L-citrulline and L-arginine: effects on the metabolism of nitric oxide. 2008;65(1):51–59.17662090
Shah PS, Shah VS, Kelly LE. Necrotizing enterocolitis in premature babies can be prevented by giving them extra arginine. 2017;4:CD004339.28399330 Cochrane Database Syst Rev.
Sieroszewski P, Suzin J, Karowicz-Bilińska A. Ultrasound evaluation of a nitric oxide donor’s intrauterine growth restriction therapy (L-arginine). 2004;15(6):363–366.15280105
Skrypnyk I, Maslova G, Lymanets T, Gusachenko I. L-arginine is a good way to keep patients with acute leukemia from getting endothelial dysfunction, which is a sign of anthracycline cardiotoxicity. Exp Oncol. 2017;39(4):308-311.29284775
Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Supplementing the diets of women with pre-eclampsia with L-arginine or a sugar pill (placebo). Acta Obstet Gynecol Scand. 2004;83(1):103-107.14678093
Stokes GS, Barin ES, Gilfillan KL, Kaesemeyer WH. How L-arginine, isosorbide mononitrate, and angiotensin II inhibitors affect the wave of the arterial pulse. Am J Hypertens. 2003;16(9, pt 1):719-724.12944028
Suzuki T, Hayase M, Hibi K, et al. How local delivery of L-arginine affects stenting in humans. Am J Cardiol. 2002;89(4):363-367.11835911
Tang WH, Wang Z, Cho L, Brennan DM, Hazen SL. Reduced global bioavailability of arginine and increased breakdown of arginine as metabolic profiles of increased cardiovascular risk. J Am Coll Cardiol. 2009;53(22):2061-2067.19477356
Tong F, Zhou X. The Nrf2/HO-1 pathway is how L-arginine works against the damage caused by ischemia and reperfusion to the kidneys in rats. 2017;42(3):519-529.28854440 Kidney Blood Press Research
Tsai PH, Tang TK, Juang CL, Chen KW, Chi CA, Hsu MC. Effects of taking arginine supplements on metabolic responses after exercise. Chin J Physiol. 2009;52(3):136-142.19777799
van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, et al. Effect of perioperative nutrition, with or without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. 2001;73(2):323–332.
Wanasen N, Soong L. L-arginine metabolism and how it affects the body’s ability to fight off infection by Leishmania. Immunol Res. 2008;41(1):15-25.18040886
Wascher TC, Bachernegg M, Kickenweiz A, et al. Involvement of the L-arginine-nitric oxide pathway in coronary artery dysfunction in guinea pig hearts caused by high blood sugar. Eur J Clin Invest. 1996;26(8):707-712.8872068
Wascher TC, Posch K, Wallner S, Hermetter A, Kostner GM, Graier WF. What effects does L-arginine have on blood vessels besides being a substrate for NO-synthase? 1997;234(1):35–38.9168955
Waugh WH, Daeschner CW 3rd, Files BA, McConnell ME, Strandjord SE. Early results from phase two of a study show that taking oral citrulline as an arginine precursor may be helpful for people with sickle cell disease.
L-arginine supplementation in peripheral arterial disease: no benefit and possible harm, by Wilson AM, Harada R, Nair N, Balasubramanian N, and Cooke JP. 2007;116(2):188–195.
Wu G, Bazer FW, Davis TA, et al. The role of nutrition and the metabolism of arginine in growth, health, and disease. Amino Acids. 2009;37(1):153-168.19030957
Yaman F, Acikan I, Dundar S, et al. Histologic and histomorphometric studies showed that arginine silicate inositol complex in the diet helped bones heal faster. Drug Des Devel Ther. 2016;10:2081-2086.27390517
Yang Y, Loscalzo J. Nitric oxide controls the amount of tissue factor that is made by human microvascular endothelial cells. 2000;101(18):2144-2148.10801753
For more details
Talk to your doctor or other healthcare provider to make sure that the information on this page applies to your situation.